DIAGNOS Stock Forecast, Price & News

0.00 (0.00 %)
(As of 06/18/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Average Volume6,539 shs
Market Capitalization$30.04 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive DGNOF News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.


DIAGNOS Inc. provides software-based interpretation services primarily in Canada, the United States, Kenya, the United Arab Emirates, Bangladesh, Saudi Arabia, and Costa Rica. It offers image analysis services through Computer Assisted Retinal Analysis, a software tool that assists health specialists in the detection of diabetic retinopathy. The company was founded in 1998 and is headquartered in Brossard, Canada.


No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.00 out of 5 stars

Business Services Sector

498th out of 505 stocks

Private Households Industry

380th out of 381 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

DIAGNOS (OTCMKTS:DGNOF) Frequently Asked Questions

What stocks does MarketBeat like better than DIAGNOS?

Wall Street analysts have given DIAGNOS a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but DIAGNOS wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is DIAGNOS's next earnings date?

DIAGNOS is scheduled to release its next quarterly earnings announcement on Friday, June 18th 2021.
View our earnings forecast for DIAGNOS

Who are DIAGNOS's key executives?

DIAGNOS's management team includes the following people:
  • Mr. Andre Larente, CEO, Pres & Exec. Director
  • Mr. Marc-André Massue, VP of Fin., CFO & Sec.
  • Mr. Guillermo Moreno Robles, VP of Sales

Who are some of DIAGNOS's key competitors?

What is DIAGNOS's stock symbol?

DIAGNOS trades on the OTCMKTS under the ticker symbol "DGNOF."

How do I buy shares of DIAGNOS?

Shares of DGNOF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DIAGNOS's stock price today?

One share of DGNOF stock can currently be purchased for approximately $0.45.

How much money does DIAGNOS make?

DIAGNOS has a market capitalization of $30.04 million and generates $250,000.00 in revenue each year.

What is DIAGNOS's official website?

The official website for DIAGNOS is www.diagnos.ca.

Where are DIAGNOS's headquarters?

DIAGNOS is headquartered at 7005 Taschereau Boulevard Suite 340, Brossard A8, J4Z 1A7.

How can I contact DIAGNOS?

DIAGNOS's mailing address is 7005 Taschereau Boulevard Suite 340, Brossard A8, J4Z 1A7. The company can be reached via phone at 450 678 8882.

This page was last updated on 6/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.